Distant Spread News Today

- CMS streamlines reimbursement for DAXXIFY with assignment of permanent J-code - - Peer-reviewed publication of DAXXIFY pivotal data in therapeutics reinforces the products long duration of effect...

- CMS streamlines reimbursement for DAXXIFY with assignment of permanent J-code -- Peer-reviewed publication of DAXXIFY pivotal data in therapeutics reinforces the products long duration of effect and favorable safety profile -NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (RVNC) today announced that...

– Q4 DAXXIFY® volume sold up 22% over Q3, reflecting positive feedback on the product’s performance profile and the new pricing strategy. – Preliminary unaudited Q4 and full year 2023...

- DAXXIFY® for Injection named to TIME’s list of the best inventions of 2023. - DAXXIFY® is a long-lasting peptide enhanced neuromodulator that delivers the first true innovation in...

/PRNewswire/ -- Galderma, the emerging pure-play dermatology category leader, today announced a new campaign to provide education and support for breast cancer...

/PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced positive topline results from the second of three Phase 3 clinical studies...

- Provides Revance entry into the $2.5 billion U.S. therapeutic neuromodulator market.1 - Approval expands the DAXXIFY® label to include efficacy data over the 52-week ASPEN repeat dose clinical... -Today at 08:04 am- MarketScreener

Received FDA approval for DAXXIFY™ (DaxibotulinumtoxinA-lanm) for injection for the treatment of glabellar linesQ3 total revenue of $29.0 million, a YoY increase of 47% with RHA® Collection revenue of $26.1 million, a YoY increase of 43%Aesthetic accounts across products and services totaled over 4,500 at quarter-en...

/PRNewswire/ -- Galderma announced today its upcoming participation in New York Citys official LGBTQIA+ Pride (NYC Pride) event. The companys aesthetics...

/PRNewswire/ -- Galderma announced the presentation of data supporting its aesthetics portfolio and pipeline at the virtual American Society for Dermatologic...